Evidence review
How to Choose a GLP-1 Telehealth Provider
A decisive 8-point checklist for picking a GLP-1 telehealth provider: the molecule, honest pricing, real prescribers, verification, and a clean exit.
On this page
The Verdict's #1 pick
CoreAge Rx
Grade AThe most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
See the verdict- Semaglutide
- $149/mo
- Tirzepatide
- $349/mo
- Coverage
- All 50 states
- Access
- Compounded
Advertising disclosure · we may earn a commission at no extra cost to you. It never changes what we write about a product or its Verdict Score.
Also ranked
Trimi Health
Grade BThe cheapest flat, month-to-month tirzepatide in the ranking at $125 — every figure below it carries a starting-dose, microdose or prepay condition — with semaglutide to match, but a missing LegitScript listing keeps it out of the trust tier.
Visit Trimi HealthMost GLP-1 telehealth providers look identical on the landing page: a hero shot, a "lose weight fast" headline, a teaser price. They are not identical. The gap between the best and worst providers is the difference between a program built to mirror what worked in the clinical trials and a program built to convert a checkout. This is the checklist we run on every provider we grade — use it in order.
1. Confirm the molecule is one that actually works
There are exactly two molecules with the trial record to justify the risk and cost: semaglutide and tirzepatide. In the pivotal STEP-1 trial, once-weekly semaglutide produced a mean body-weight reduction of roughly 15% over 68 weeks1. Tirzepatide went further in SURMOUNT-1, with the top dose reaching about a 21% reduction over 72 weeks2. If a provider is selling anything else as a "GLP-1 alternative" — research peptides, unproven blends, homeopathic drops — close the tab. Once you have picked a molecule, the shortlist narrows fast: see who we rule for on tirzepatide. Before you get this far, it is also worth confirming you actually meet the label's criteria for either molecule — see who qualifies for a GLP-1, and who shouldn't take one for the specific BMI thresholds and exclusions.
2. Demand honest, all-in pricing
The single most common trap is the teaser rate: a low first-month price that silently triples on the second charge. A provider worth your money publishes one flat, all-in monthly cost — medication, consult, and shipping — with no surprise membership or lab fees stacked on later. If you cannot find the real ongoing price in under a minute, that is the answer. For a ranking already sorted on that basis, see what a GLP-1 really costs without insurance. See what compounded GLP-1 actually costs per month for the current ranges, and run any shortlist through the true cost calculator — it applies each provider's own step-ups and commitments so the teaser rate cannot flatter itself. Two providers we screened in August 2026 show both ends of this test: The Edit publishes prepay figures that divide correctly into the monthly rate beside them, while a company whose loudest number matches no program it sells puts every real price behind a login.
3. Check that a real prescriber stands behind it
A legitimate provider routes you to a licensed clinician who reviews your history before prescribing — not a form that rubber-stamps an order. Look for a named medical team, a genuine intake questionnaire, and the ability to reach a prescriber with a side-effect question after you start. That review should cover your full medication list, since semaglutide and tirzepatide carry real, documented drug interactions — birth control and blood thinners among them — and it should ask about your eye and vascular health, given the emerging NAION vision-loss signal now in the literature.
4. Verify the pharmacy
Compounded GLP-1 medications are not FDA-approved finished drug products; the FDA does not review them for safety, effectiveness, or quality the way it reviews brand-name drugs3. That makes the pharmacy behind the prescription the whole ballgame. Favor providers that work with a LegitScript-certified operation and will tell you whether their compounding is done under 503A (patient-specific) or 503B (an FDA-registered outsourcing facility). Our full reasoning is in how to tell whether compounded semaglutide is safe to buy. Ask specifically how the pharmacy walks first-time patients through drawing up a dose — the FDA has documented real, hospitalization-level dosing errors with compounded semaglutide vials, and a provider that hands you a vial with nothing more than a printed insert has skipped exactly the step that prevents them. If a "provider" is selling a sticker patch instead of an injection or an FDA-approved tablet, that is a bigger red flag than a low price — see why GLP-1 patches can't actually work. It helps to know what a complete answer to this question looks like, because it is rare: Pallas Health names all six of its dispensing pharmacies and two prescribing physicians with checkable NPI numbers, which is the disclosure standard to hold the rest of the field to — even where, as there, the pricing structure earns a much harsher verdict.
5. Match the formulary to your plan
Do you want the option to switch from semaglutide to tirzepatide later? To move to brand-name Wegovy or Zepbound if compounded supply tightens? To use an oral route instead of injections? Formulary breadth only matters if it matches what you actually intend to do — but if you want options, pick a provider that has them on one account rather than forcing a re-signup elsewhere.
6. Confirm it serves your state
Telehealth prescribing is state-by-state. A provider available in "all 50 states" removes a variable; a 15-state operator may not cover you at all. Check this before you get attached to a brand — and treat a provider that will not answer as its own category, because Auren Rx never publishes a state list anywhere on its site, which is the one hole in an otherwise unusually complete disclosure record.
7. Read the cancellation terms first
The cleanest tell of how a company treats you is how hard it makes leaving. Before you pay, find out whether you can pause, switch molecules, or cancel in a couple of clicks — or whether you are locked into auto-ship and contract terms designed to make quitting painful.
8. Weigh support after the first vial ships
Titration is where people succeed or quit. Nausea, dosing questions, a weight-loss plateau months in — you want a provider whose support does not evaporate the moment the medication is in the mail. That support should also help you make sense of what your body is doing along the way, whether that is noticeable hair shedding or facial volume change, and it should know to flag the warning signs of gallbladder or pancreas problems rather than waving off abdominal pain as routine nausea.
The bottom line
Run providers through these eight points in order and most of the field eliminates itself on price honesty and verification alone. That is exactly what our Verdict Score methodology does at scale — same rubric, every provider — so you can start from the ranked reviews instead of a blank search bar.
Frequently asked questions
What is the single most important factor?
Verification and price honesty, together. A provider that hides its ongoing price or its pharmacy fails before any other factor matters.
Is compounded or brand-name the better choice?
It depends on cost and supply. See our compounded vs brand-name guide — brand-name is FDA-approved; compounded is typically cheaper but not FDA-approved.
How do I know a provider serves my state?
Check the provider's own states-served disclosure before signing up. Nationwide (all 50 states) providers remove that variable entirely.
References
The 3 sources below are cited in full, and this guide sits alongside the rest of our evidence library, where every claim about the medicine traces to a trial, a label or the regulatory record.
- Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/33567185/
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/35658024/
- U.S. Food and Drug Administration (2024). Compounding and the FDA: Questions and Answers (503A and 503B). FDA. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Continue reading
Compounded vs Brand-Name GLP-1: Which Should You Choose?
Brand-name GLP-1 is FDA-approved and consistent; compounded is cheaper and more available but not FDA-approved. Here is how to decide honestly.
ReadWhat Compounded GLP-1 Costs Per Month
Compounded semaglutide runs roughly $93–$249/mo and tirzepatide about $125–$399/mo across the providers we track. Here is how to read the pricing.
ReadSemaglutide vs Tirzepatide: Which Is Right for You?
Tirzepatide wins on raw weight loss in the trials; semaglutide is the longer-established, often cheaper option. Here is how to decide between them.
ReadIs Compounded Semaglutide Legit and Safe?
Compounded semaglutide is legal but not FDA-approved. Safety hinges on the pharmacy. Here is how to tell a legitimate program from a risky one.
ReadHow We Grade GLP-1 Providers: The Verdict Score Explained
The Verdict Score rates every GLP-1 provider out of 100 on six weighted factors — the same rubric for every provider, and the score is never sold.
ReadWhat the End of GLP-1 Compounding Means for You
The FDA shortage that made compounded semaglutide and tirzepatide widely available is over. Here is who can still get compounded GLP-1 and who must switch.
Read